Clinical Trials / Research Studies
Medulloblastoma New Diagnosis

Medulloblastoma New Diagnosis

ACNS2031: A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

  • Ages: 3 Years to 21 Years

This phase III trial tests the addition of sodium thiosulfate to standard of care chemotherapy and radiation therapy in treating patients with low or average risk medulloblastoma (a type of cancer in the brain). Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Chemoth ...More